Considerations for Unblinding in Biopharmaceutical Industry Sponsored Trials
- PMID: 30339068
- DOI: 10.1080/15265161.2018.1513588
Considerations for Unblinding in Biopharmaceutical Industry Sponsored Trials
Comment on
-
Ethical Considerations for Unblinding a Participant's Assignment to Interpret a Resolved Adverse Event.Am J Bioeth. 2018 Oct;18(10):66-67. doi: 10.1080/15265161.2018.1522167. Am J Bioeth. 2018. PMID: 30339065 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources